DMD and Duchenne muscular dystrophy: A CRISPR-guided cytidine deaminase was used to mutate the 5′ splice site of exon 50 of DMD in iPSCs derived from a DMD patient who lacked dystrophin because of a deletion of exon 51 (Table 2) [161].